Cargando…
MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction
BACKGROUND: Our study aim was to evaluate the therapeutic efficacy and mechanisms of miR-133-overexpressing mesenchymal stem cells (MSCs) on acute myocardial infarction. METHODS: Rat MSCs were isolated and purified by whole bone marrow adherent culturing. After transfection with the agomir or antago...
Autores principales: | Chen, Yueqiu, Zhao, Yunfeng, Chen, Weiqian, Xie, Lincen, Zhao, Zhen-Ao, Yang, Junjie, Chen, Yihuan, Lei, Wei, Shen, Zhenya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5702098/ https://www.ncbi.nlm.nih.gov/pubmed/29178928 http://dx.doi.org/10.1186/s13287-017-0722-z |
Ejemplares similares
-
The enhanced effect and underlying mechanisms of mesenchymal stem cells with IL-33 overexpression on myocardial infarction
por: Chen, Yueqiu, et al.
Publicado: (2019) -
MicroRNA-132, Delivered by Mesenchymal Stem Cell-Derived Exosomes, Promote Angiogenesis in Myocardial Infarction
por: Ma, Teng, et al.
Publicado: (2018) -
MicroRNA-133a and Myocardial Infarction
por: Xiao, Yi, et al.
Publicado: (2019) -
Downregulation of MicroRNA-206 Alleviates the Sublethal Oxidative Stress-Induced Premature Senescence and Dysfunction in Mesenchymal Stem Cells via Targeting Alpl
por: Liu, Xuan, et al.
Publicado: (2020) -
Engineered Exosomes With Ischemic Myocardium‐Targeting Peptide for Targeted Therapy in Myocardial Infarction
por: Wang, Xu, et al.
Publicado: (2018)